STAGE III BLADDER CANCER AJCC V8
Clinical trials for STAGE III BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Cancer's weak spot: a hopeful trial for Tough-to-Treat tumors
Disease control Recruiting nowThis study is testing whether a pill called olaparib can help control advanced bladder and other urinary cancers that have specific DNA repair defects and have stopped responding to standard treatments like chemotherapy. The drug works by blocking a protein that helps cancer cell…
Matched conditions: STAGE III BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New attack on tough cancers: drugs then surgery
Disease control Recruiting nowThis study is for people with advanced bladder or upper urinary tract cancer that has spread. It tests if using two standard cancer drugs first, followed by surgery to remove the bladder or ureter, helps control the cancer better and for longer. The goal is to see if this combine…
Matched conditions: STAGE III BLADDER CANCER AJCC V8
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New support program aims to help bladder cancer patients navigate complex treatment
Symptom relief Recruiting nowThis study is testing an education and navigation support tool designed to help patients with advanced bladder cancer and their caregivers participate more actively in treatment decisions and care planning. The program provides educational resources, connects patients to support …
Matched conditions: STAGE III BLADDER CANCER AJCC V8
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Feb 17, 2026 14:36 UTC